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Abstract
The Neuropeptide FF receptor family contains two subtypes, NPFF1 and NPFF2 (provisional nomenclature
[10]), which exhibit high affinities for neuropeptide FF (NPFF, O15130) and RFamide related peptides (RFRP:
precursor gene symbol NPVF, Q9HCQ7). NPFF1 is broadly distributed in the central nervous system with the
highest levels found in the limbic system and the hypothalamus. NPFF2 is present in high density in the
superficial layers of the mammalian spinal cord where it is involved in nociception and modulation of opioid
functions.
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